期刊文献+

RNA干扰组蛋白去乙酰化酶1对人胰腺癌细胞增殖、凋亡的调控机制研究 被引量:8

Mechanism of RNA interference on proliferation and apoptosis regulation of pancreatic cancer cell line PaTu8988 by HDAC1 siRNA
下载PDF
导出
摘要 目的观察沉默组蛋白去乙酰化酶1(HDAC1)基因对人胰腺癌PaTu8988细胞增殖、凋亡的影响及可能机制。方法胰腺癌PaTu8988细胞株分为空白对照组(不予任何处理)、阴性对照siRNA组(予以30nmol/L阴性siRNA)、siRNA1组(予以15nmol/LHDAC1siRNA)和siRNA2组(予以30nmol/LHDAC1siRNA)。siRNA转染48h后,用相对实时定量RT-PCR法和West-ernblotting检测HDAC1基因表达情况;相对实时定量RT-PCR法检测细胞增殖凋亡相关基因p21、Bcl-2、Bax的表达;WST-8法检测细胞增殖情况;流式细胞术检测细胞凋亡变化。结果转染HDAC1siRNA48h后人胰腺癌PaTu8988细胞中HDAC1mRNA表达量在siRNA1组和siRNA2组分别为46.1%±6.1%和32.3%±1.4%,均显著低于空白对照组(100.0%±3.4%)和阴性对照siRNA组(87.4%±28.3%,P<0.05)。Westernblotting显示HDAC1蛋白表达量亦明显下降,以siRNA2组表达量最低(P<0.05)。WST-8法检测显示4组细胞存活率分别为100%±17.1%、87.1%±5.0%、68.7%±4.7%、61.6%±2.0%,siRNA1组和siRNA2组与其他各组相比差异显著(P<0.05)。流式细胞术检测显示上述4组胰腺癌细胞凋亡率分别为4.20%±0.95%,4.59%±1.26%,10.09%±1.36%,11.19%±6.07%,与空白对照组和阴性对照siRNA组相比,siRNA1组和siRNA2组凋亡率显著增高(P<0.05)。siRNA1组和siRNA2组p21、BaxmRNA相对表达量明显高于其他各组(P<0.05),而Bcl-2mRNA相对表达量明显低于其他各组(P<0.05)。结论HDAClsiRNA能特异、有效地抑制人胰腺癌PaTu8988细胞HDACl的表达,同时抑制细胞增殖、诱导细胞凋亡,其机制可能与上调p21、Bax表达,下调Bcl-2表达有关。 Objective To investigate the effects of histone deacetylase 1 (HDAC1) gene silencing on cell proliferation and apoptosis of pancreatic cancer cell line PaTu8988.Methods PaTu8988 cells were cultured and divided into four groups:control group (untreated),negative siRNA group (treated with 30nmol/L negative control siRNA),siRNA1 group (treated with 15nmol/L HDACl siRNA) and siRNA2 group (treated with 30nmol/L HDACl siRNA).RT-PCR and Western blotting were used to detect the gene expression of HDAC1 48 hours after HDAC1 siRNA transfection.The expression of p21,Bax and bcl-2 mRNA was detected by RT-PCR.Cell proliferation and apoptosis were evaluated using cell counting kit and flow cytometry,respectively.Results After HDAC1 siRNA trasnfection,the expression of HDAC1 mRNA in PaTu8988 cells was 46.1%±6.1% in siRNA1 group and 32.3%±1.4% in siRNA2 group,respectively,and they were significantly lower than that in control group (100.0%±3.4%,P0.05) and in negative siRNA group (87.4%±28.3%,P0.05).Western blotting showed that the expression of HDAC1 protein decreased,especially in siRNA2 group (P0.05).Cell survival rate was 100%±17.1% in control group,87.1%±5.0% in negative control siRNA group,68.7%±4.7% in siRNA1 group and 61.6%±2.0% in siRNA2 group,and significant difference existed between the latter two groups (P0.05).Cell apoptosis rate was 4.20%±0.95%,4.59%±1.26%,10.09%±1.36% and 11.19%±6.07% respectively,in the four groups,and significantly increased in siRNA1 and siRNA2 group (P0.05).The mRNA expression of p21 and Bax was higher than that in other two groups (P0.05),while that of Bcl-2 was lower (P0.05).Conclusions HDACl siRNA can efficiently and specifically inhibit the expression of HDAC1 and the proliferation of PaTu8988 cells,and meanwhile induce cell apoptosis,which may be attributable to up-regulation of p21 and Bax,and down-regulation of bcl-2 mRNA expression.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2010年第4期380-383,共4页 Medical Journal of Chinese People's Liberation Army
基金 温州市科技局资助项目(Y20090102)
关键词 基因 HDAC1 胰腺肿瘤 RNA干扰 细胞增殖 细胞凋亡 gene HDAC1 pancreatic neoplasms RNA interference cell proliferation cell apoptosis
  • 相关文献

参考文献11

  • 1Jones PA, Martienssen R. A blueprint for a human epigenome project : the AACR human epigenome workshop[J]. Cancer Res, 2005, 65(24) :11241-11246.
  • 2Marks P, Rifkind RA, Riehon VM, et al. Histone deacetylases and cancer: causes and therapies[J]. Nat Rev Cancer, 2001, 1(3) : 194-202.
  • 3Halkidou K, Gaughan L, Cook S, et al. Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer[J].Prostate, 2004, 59(2) :177-189.
  • 4Wilson AJ, Byun DS, Popova N, et al. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer[J]. J Biol Chem, 2006, 281(19): 13548-13558.
  • 5Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of eancer[J]. Nat Rev Drug Discov, 2002, 1(4) :287-299.
  • 6Richon VM, Zhou X, Rifldnd RA, et al. Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers[J]. Blood Cells Mol Dis, 2001, 27(1):260 264.
  • 7Glaser KB, Stayer MJ, Waring JF, et al. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA earcinoma cell lines[J]. Mol Cancer Ther, 2003, 2(2) : 151-163.
  • 8Bemstein BE, Tong JK, Schreiber SL. Genomewide studies of histone deacetylase function in yeast[J]. Proc Natl Acad Sci U S A, 2000, 97(25) :13708-13713.
  • 9Krajewski S, Kraiewska M, Shabaik A, et al. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2[J]. Am H Pathol, 1994, 145(6) :1323-1336.
  • 10Baldi A, Groeger AM, Esposito V, et al. Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival[J]. Thorax, 2002, 57(4) :353-356.

同被引文献55

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部